211 related articles for article (PubMed ID: 23234587)
1. Rhabdomyolysis reported for children and adolescents treated with antipsychotic medicines: a case series analysis.
Star K; Iessa N; Almandil NB; Wilton L; Curran S; Edwards IR; Wong IC
J Child Adolesc Psychopharmacol; 2012 Dec; 22(6):440-51. PubMed ID: 23234587
[TBL] [Abstract][Full Text] [Related]
2. Adverse drug reactions of statins in children and adolescents: a descriptive analysis from VigiBase, the WHO global database of individual case safety reports.
Conte C; Rousseau V; Vert C; Montastruc F; Montastruc JL; Durrieu G; Olivier P
Fundam Clin Pharmacol; 2020 Aug; 34(4):518-520. PubMed ID: 32022302
[TBL] [Abstract][Full Text] [Related]
3. Suspected adverse drug reactions reported for children worldwide: an exploratory study using VigiBase.
Star K; Norén GN; Nordin K; Edwards IR
Drug Saf; 2011 May; 34(5):415-28. PubMed ID: 21513364
[TBL] [Abstract][Full Text] [Related]
4. Role of serotonin 5-HT2C and histamine H1 receptors in antipsychotic-induced diabetes: A pharmacoepidemiological-pharmacodynamic study in VigiBase.
Montastruc F; Palmaro A; Bagheri H; Schmitt L; Montastruc JL; Lapeyre-Mestre M
Eur Neuropsychopharmacol; 2015 Oct; 25(10):1556-65. PubMed ID: 26256010
[TBL] [Abstract][Full Text] [Related]
5. Comparative safety of antipsychotics in the WHO pharmacovigilance database: the haloperidol case.
Meyer-Massetti C; Vaerini S; Rätz Bravo AE; Meier CR; Guglielmo BJ
Int J Clin Pharm; 2011 Oct; 33(5):806-14. PubMed ID: 21809143
[TBL] [Abstract][Full Text] [Related]
6. Massive asymptomatic creatine kinase elevation in youth during antipsychotic drug treatment: case reports and critical review of the literature.
Masi G; Milone A; Viglione V; Mancini A; Pisano S
J Child Adolesc Psychopharmacol; 2014 Dec; 24(10):536-42. PubMed ID: 25387323
[TBL] [Abstract][Full Text] [Related]
7. Allergy-like immediate reactions with herbal medicines in children: A retrospective study using data from VigiBase
Meincke R; Pokladnikova J; Straznicka J; Meyboom RHB; Niedrig D; Russmann S; Jahodar L
Pediatr Allergy Immunol; 2017 Nov; 28(7):668-674. PubMed ID: 28846157
[TBL] [Abstract][Full Text] [Related]
8. Remdesivir in the COVID-19 Pandemic: An Analysis of Spontaneous Reports in VigiBase During 2020.
Rocca E; Gauffin O; Savage R; Vidlin SH; Grundmark B
Drug Saf; 2021 Sep; 44(9):987-998. PubMed ID: 34374967
[TBL] [Abstract][Full Text] [Related]
9. Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®.
Ampadu HH; Hoekman J; de Bruin ML; Pal SN; Olsson S; Sartori D; Leufkens HG; Dodoo AN
Drug Saf; 2016 Apr; 39(4):335-45. PubMed ID: 26754924
[TBL] [Abstract][Full Text] [Related]
10. Adverse drug reactions of botulinum neurotoxin type A in children with cerebral palsy: a pharmaco-epidemiological study in VigiBase.
Montastruc J; Marque P; Moulis F; Bourg V; Lambert V; Durrieu G; Montastruc JL; Montastruc F
Dev Med Child Neurol; 2017 Mar; 59(3):329-334. PubMed ID: 27682175
[TBL] [Abstract][Full Text] [Related]
11. Statins, neuromuscular degenerative disease and an amyotrophic lateral sclerosis-like syndrome: an analysis of individual case safety reports from vigibase.
Edwards IR; Star K; Kiuru A
Drug Saf; 2007; 30(6):515-25. PubMed ID: 17536877
[TBL] [Abstract][Full Text] [Related]
12. Aripiprazole-Associated Rhabdomyolysis in a 17-Year-Old Male.
Kutlu A; Songür ÇY; Apa H
Arch Iran Med; 2023 Jan; 26(1):50-53. PubMed ID: 37543922
[TBL] [Abstract][Full Text] [Related]
13. Seizure risk associated with neuroactive drugs: data from the WHO adverse drug reactions database.
Kumlien E; Lundberg PO
Seizure; 2010 Mar; 19(2):69-73. PubMed ID: 20036167
[TBL] [Abstract][Full Text] [Related]
14. Paediatric atypical antipsychotic monitoring safety (PAMS) study: pilot study in children and adolescents in secondary- and tertiary-care settings.
Rani FA; Byrne PJ; Murray ML; Carter P; Wong IC
Drug Saf; 2009; 32(4):325-33. PubMed ID: 19388723
[TBL] [Abstract][Full Text] [Related]
15. Olanzapine-induced rhabdomyolysis.
Rosebraugh CJ; Flockhart DA; Yasuda SU; Woosley RL
Ann Pharmacother; 2001 Sep; 35(9):1020-3. PubMed ID: 11573848
[TBL] [Abstract][Full Text] [Related]
16. Adverse reaction reports of neuroleptic malignant syndrome induced by atypical antipsychotic agents in the Japanese Adverse Drug Event Report (JADER) database.
Anzai T; Takahashi K; Watanabe M
Psychiatry Clin Neurosci; 2019 Jan; 73(1):27-33. PubMed ID: 30375086
[TBL] [Abstract][Full Text] [Related]
17. Neurological, Metabolic, and Psychiatric Adverse Events in Children and Adolescents Treated With Aripiprazole.
Jakobsen KD; Bruhn CH; Pagsberg AK; Fink-Jensen A; Nielsen J
J Clin Psychopharmacol; 2016 Oct; 36(5):496-9. PubMed ID: 27504593
[TBL] [Abstract][Full Text] [Related]
18. Rates of spontaneous reports of adverse drug reactions for drugs reported in children: a cross-sectional study with data from the Swedish adverse drug reaction database and the Swedish Prescribed Drug Register.
Wallerstedt SM; Brunlöf G; Sundström A
Drug Saf; 2011 Aug; 34(8):669-82. PubMed ID: 21751827
[TBL] [Abstract][Full Text] [Related]
19. Reported Adverse Drug Reactions in Children and Adolescents Treated with Antipsychotics.
Minjon L; van den Ban E; de Jong E; Souverein PC; Egberts TCG; Heerdink ER
J Child Adolesc Psychopharmacol; 2019 Mar; 29(2):124-132. PubMed ID: 30676073
[TBL] [Abstract][Full Text] [Related]
20. Overdoses and ingestions of second-generation antipsychotics in children and adolescents.
Antia SX; Sholevar EH; Baron DA
J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):970-85. PubMed ID: 16379518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
